Tirzepatide
Dual GIP and GLP-1 Receptor Agonist
Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. Available as FDA-approved Mounjaro® for Type 2 diabetes and Zepbound® for weight management and obstructive sleep apnea. It provides superior weight loss and glycemic control compared to single-pathway medications through its unique dual mechanism of action.
Comprehensive Dosing Guide
Patient Education
Helping you understand how to use tirzepatide properly is key to your success. Here's what you need to know:
How to Inject Tirzepatide Correctly
Before You Start:
- Check the pen for any damage or discoloration.
- Make sure the medicine looks clear. Don't use it if it's cloudy or has particles.
Steps to Inject:
- Wash your hands with soap and water.
- Take off the pen cap and make sure the dose is correct.
- Clean the area where you'll inject (belly, thigh, or upper arm) with an alcohol wipe and let it dry.
- Pinch your skin lightly and insert the needle at a 45- to 90-degree angle.
- Press and hold the injection button until the dose counter goes back to zero.
- Pull out the needle and throw it away safely in a sharps container.
Changing Injection Spots:
- Use a different spot each week to avoid skin problems.
- Don't inject where you have scars, moles, or a lot of hair.
Medical Disclaimer
Tirzepatide is FDA-approved as Mounjaro® for Type 2 diabetes and Zepbound® for chronic weight management. This information is for educational purposes and should not replace consultation with healthcare providers. Individual results may vary. Prescribing information and medical supervision are required for all therapeutic uses.